Anaplastic lymphoma kinase as a therapeutic target

Author： Kruczynski Anna Delsol Georges Laurent Camille Brousset Pierre Lamant Laurence

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.11, 2012-11, pp. : 1127-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

The Syk kinase as a therapeutic target in leukemia and lymphoma

By Efremov Dimitar G Laurenti Luca

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 623-636

Informa Healthcare

Access to resources Recommend Favorite

Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 236-243

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of anaplastic lymphoma kinase: a patent review

By Milkiewicz Karen L Ott Gregory R

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1653-1681

Informa Healthcare

Access to resources Recommend Favorite

Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy

By Coluccia AML Gunby RH Tartari CJ Scapozza L Gambacorti-Passerini C Passoni Lorena

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 515-532

Informa Healthcare

Access to resources Recommend Favorite